Testing effectiveness (Phase 2)Ended earlyNCT00111917What this trial is testingBeryllium Infliximab Study: Clinical Interventional TrialWho this might be right forBerylliosisBeryllium Disease Maier, Lisa, M.D. 13
Testing effectiveness (Phase 2)Study completedNCT01088243What this trial is testingTargeting Oxidative Stress in Chronic Beryllium DiseaseWho this might be right forChronic Beryllium Disease National Jewish Health 18
Not applicableStudy completedNCT00560989What this trial is testingIdentifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and SarcoidosisWho this might be right forSarcoidosisBerylliosis National Jewish Health 400
Not applicableUnknownNCT06113991What this trial is testingStudy Comparing Chronic Beryllium Disease to Pulmonary SarcoidosisWho this might be right forPulmonary SarcoidosisChronic Beryllium Disease Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT02596347What this trial is testingThe Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)Who this might be right forChronic Beryllium Disease (CBD)Beryllium Sensitization (BeS) National Jewish Health 3
Not applicableStudy completedNCT02604693What this trial is testingExposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)Who this might be right forChronic Beryllium Disease National Jewish Health 148